PIK3CA and colorectal carcinoma: The coculture of GFP-labelled tumour spheres with CAFs protected cells from taselisib treatment (figure 2G), suggesting that CAFs could play a critical role in opposition to the killing activity of PI3K inhibitors in CRC.